BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 37215138)

  • 1. SIRT2 plays complex roles in neuroinflammation neuroimmunology-associated disorders.
    Lu W; Ji H; Wu D
    Front Immunol; 2023; 14():1174180. PubMed ID: 37215138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRT2: Controversy and multiple roles in disease and physiology.
    Wang Y; Yang J; Hong T; Chen X; Cui L
    Ageing Res Rev; 2019 Nov; 55():100961. PubMed ID: 31505260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple Roles of SIRT2 in Regulating Physiological and Pathological Signal Transduction.
    Zhu C; Dong X; Wang X; Zheng Y; Qiu J; Peng Y; Xu J; Chai Z; Liu C
    Genet Res (Camb); 2022; 2022():9282484. PubMed ID: 36101744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Will Sirtuin 2 Be a Promising Target for Neuroinflammatory Disorders?
    Fan Z; Bin L
    Front Cell Neurosci; 2022; 16():915587. PubMed ID: 35813508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirtuin 2 (SIRT2): Confusing Roles in the Pathophysiology of Neurological Disorders.
    Chen X; Lu W; Wu D
    Front Neurosci; 2021; 15():614107. PubMed ID: 34108853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of NAD-Dependent Deacetylase SIRT2 Protects Mouse Brain Against Ischemic Stroke.
    Xie XQ; Zhang P; Tian B; Chen XQ
    Mol Neurobiol; 2017 Nov; 54(9):7251-7261. PubMed ID: 27796760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the anti-inflammatory effect of SIRT1 and SIRT2 modulators on neurodegenerative diseases.
    Zhang Y; Anoopkumar-Dukie S; Arora D; Davey AK
    Eur J Pharmacol; 2020 Jan; 867():172847. PubMed ID: 31812544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting p53 for neuroinflammation: New therapeutic strategies in ischemic stroke.
    Gao J; Liu J; Li Y; Liu J; Wang H; Chai M; Dong Y; Zhang Z; Su G; Wang M
    J Neurosci Res; 2023 Sep; 101(9):1393-1408. PubMed ID: 37156641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT1 and SIRT2: emerging targets in neurodegeneration.
    Donmez G; Outeiro TF
    EMBO Mol Med; 2013 Mar; 5(3):344-52. PubMed ID: 23417962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockout of silent information regulator 2 (SIRT2) preserves neurological function after experimental stroke in mice.
    Krey L; Lühder F; Kusch K; Czech-Zechmeister B; Könnecke B; Fleming Outeiro T; Trendelenburg G
    J Cereb Blood Flow Metab; 2015 Dec; 35(12):2080-8. PubMed ID: 26219598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Communicable Neurological Disorders and Neuroinflammation.
    Ballerini C; Njamnshi AK; Juliano SL; Kalaria RN; Furlan R; Akinyemi RO
    Front Immunol; 2022; 13():834424. PubMed ID: 35769472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRT2 Inhibition Confers Neuroprotection by Downregulation of FOXO3a and MAPK Signaling Pathways in Ischemic Stroke.
    She DT; Wong LJ; Baik SH; Arumugam TV
    Mol Neurobiol; 2018 Dec; 55(12):9188-9203. PubMed ID: 29654491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis.
    North BJ; Verdin E
    PLoS One; 2007 Aug; 2(8):e784. PubMed ID: 17726514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective.
    Kumar V; Kundu S; Singh A; Singh S
    Curr Neuropharmacol; 2022; 20(1):158-178. PubMed ID: 34151764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Special issue: Neuroinflammatory pathways as treatment targets in brain disorders autophagic regulation of neuroinflammation in ischemic stroke.
    Zheng Y; Zhou Z; Han F; Chen Z
    Neurochem Int; 2021 Sep; 148():105114. PubMed ID: 34192589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key players of the necroptosis pathway RIPK1 and SIRT2 are altered in placenta from preeclampsia and fetal growth restriction.
    Hannan NJ; Beard S; Binder NK; Onda K; Kaitu'u-Lino TJ; Chen Q; Tuohey L; De Silva M; Tong S
    Placenta; 2017 Mar; 51():1-9. PubMed ID: 28292463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell lines.
    Kozako T; Mellini P; Ohsugi T; Aikawa A; Uchida YI; Honda SI; Suzuki T
    BMC Cancer; 2018 Aug; 18(1):791. PubMed ID: 30081901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirtuin 2 (SIRT2) enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via deacetylating forkhead box O3a (Foxo3a) and activating Bim protein.
    Liu L; Arun A; Ellis L; Peritore C; Donmez G
    J Biol Chem; 2012 Sep; 287(39):32307-11. PubMed ID: 22898818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT2 Affects Cell Proliferation and Apoptosis by Suppressing the Level of Autophagy in Renal Podocytes.
    Liu S; Gao X; Fan Z; Wang Q
    Dis Markers; 2022; 2022():4586198. PubMed ID: 35493297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NAD-dependent deacetylase SIRT2 regulates T cell differentiation involved in tumor immune response.
    Jiang C; Liu J; Guo M; Gao X; Wu X; Bai N; Guo W; Li N; Yi F; Cheng R; Xu H; Zhou T; Jiang B; Sun T; Wei S; Cao L
    Int J Biol Sci; 2020; 16(15):3075-3084. PubMed ID: 33061819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.